RE:MINDCURE Provides Update on Studies and Clinical TrialsGreat update BUT MCUR DOWN A PENNY ON THE NEWS!
Management and advisors are being paid
$$$EXTREMELY WELL$$$
But REVENUE is ZERO
This business model is not substainable
A cheap PP is not the way to do it
SHAREHOLDERS ARE GETTING A BIG NEGATIVE RETURN AND
ARE NEVER MENTIONED IN CONFERENCE PRESENTATIONS
We have got a lot of PRESTIGE Doctorates on the payroll
More than enough
Need a Streetsmart Well Known marketwise director on board soon
to get stock to rally
Marketmaker and Stockbrokerage Presentations should follow
CMPS and ATAI the big Psychedelic stocks are rallying great now
They have the HIGH PROFILE PEOPLE BEHIND THEM
MCUR @ .31 we have a lot of catching up to do
It is just matter of implementation of the tried and proven method